Gene Editing Market Size Forecast: Revenue and CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Gene Editing Industry Expected To Reach By 2029, Starting From 2025 Levels?

The gene editing market size has seen significant expansion in recent times. It is projected to increase from $8.82 billion in 2024 to $10.31 billion in 2025, achieving a compound annual growth rate (CAGR) of 17.0%. The historical growth of this market can be linked to factors such as the discovery of crispr-cas9, progress in genetic sequencing, notable medical breakthroughs, funding for scientific research, and the overall development of the biotechnology industry.

The gene editing market size is anticipated to undergo significant expansion in the coming years, reaching a valuation of $20.62 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 18.9%. This projected growth is primarily driven by the broadening of therapeutic applications, advancements in precision and efficiency, the commercialization of gene therapy, the evolution of agricultural applications, and the growth in regenerative medicine. Noteworthy trends for this forecast period encompass multiplex editing techniques, innovations in base editing, the utilization of gene drives and population modification, the development of non-viral delivery systems, and progress in disease modeling and drug discovery.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

Which Drivers Are Supporting Growth Of The Gene Editing Market?

The growing occurrence of communicable diseases is a key factor driving the gene editing market, making gene editing techniques essential for their detection and management. Communicable diseases are conditions caused by infectious agents such as bacteria, viruses, or parasites, which can spread among individuals, from animals, or from the environment. Gene editing technologies are increasingly being utilized to develop precise methods capable of identifying and combating pathogens at a genetic level, thereby enhancing efforts in disease control and prevention. For example, in 2023, the World Economic Forum, a Switzerland-based international non-governmental organization, noted an increase in infections like influenza and respiratory syncytial virus (RSV) since the pandemic. In the USA, by February 2023, influenza had resulted in an estimated 24 million illnesses, 260,000 hospitalizations, and 16,000 deaths. Additionally, in 2022, the World Health Organization reported that 10.6 million people globally were infected with tuberculosis, with 1.3 million deaths attributed to the disease. Therefore, communicable diseases are significantly propelling the gene editing market.

What Are The Primary Types Of Segments Analyzed In The Gene Editing Market?

The gene editingmarket covered in this report is segmented –

1) By Technology: CRISPR; TALEN; ZFN

2) By Application: Animal Genetic Engineering; Plant Genetic Engineering; Cell Line Engineering

3) By End Users: Biotechnology; Pharmaceutical; Contract Research Organization

Subsegments:

1) By CRISPR: CRISPR-Cas9; CRISPR-Cas12; CRISPR-Cas13; CRISPR-based Gene Drives

2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs; Commercial TALEN Kits

3) By ZFN (Zinc Finger Nucleases): Custom ZFNs; Commercial ZFN Kits

What Trends Are Expected To Drive The Gene Editing Market?

Major companies operating in the gene editing markets are rolling out innovative gene editing technology, such as a method centered on special cell-penetrating peptides that offers superior benefits compared to existing approaches, aiming to secure a competitive advantage in the market. This strategy could also fuel the creation of advanced cell therapies for cancer and various other diseases. For instance, in April 2023, Penn Medicine, a US-based major multi-hospital health system, identified that protein fragments employed by certain viruses for cell entry could similarly facilitate the delivery of CRISPR-Cas gene editing molecules into cells and their DNA-containing nuclei with extraordinarily high efficiency and low cellular toxicity. Scientists predict this new technique will be exceptionally valuable for modifying T cells and other cells sourced from a patient’s own body to develop cell therapies. A key application could be CAR T (chimeric antigen receptor T cell) therapy, which involves using specially modified immune cells from a patient to treat cancer. This novel approach to the genetic engineering of cells promises substantial enhancements in speed, efficiency, and a reduction in cellular toxicity when weighed against current methodologies.

Who Are The Primary Competitors In The Global Gene Editing Market?

Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Gene Editing Market?

North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gene Editing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp

Browse Through More Reports Similar to the Global Gene Editing Market 2025, By The Business Research Company

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Biologics Market 2025

https://www.thebusinessresearchcompany.com/report/biologics-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795